Category: Health & Medicines > Medicines > Tacrolimus
Country/Region: China State/Province: Shanghai
Main Products: APIS, Intermediates
Business Type: Manufacturer, Trader
Year Established: 2004
Employees: 101 - 200 People
Plant Area: 10,000-30,000 square meters
Main Markets: South America 8% Africa 11% Eastern Asia 11% Domestic Market 12% North America 12% Eastern Europe 11% Southern Europe 9% Mid East 9% Northern Europe 8% Oceania 9%
Trade Capacity: FOB, CIP, DEQ
Contract Manufacturing: OEM Service Offered
Nearest Port: Shanghai
Annual Revenue: US$10 Million - US$50 Million
Total Revenue: Above US$100 Million
Export Revenue: US$10 Million - US$50 Million
Annual Output: US$10 Million - US$50 Million
Registered Capital: US$50 Million - US$100 Million
Export Percentage: 51% - 60%
Payment Modes: USD, EUR, CNY
Lead Time: 6 days
Import/Export Mode: LLC (Limited Liability Corp)